This map shows the geographic impact of S Spinaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Spinaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Spinaci more than expected).
This network shows the impact of papers produced by S Spinaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Spinaci. The network helps show where S Spinaci may publish in the future.
Co-authorship network of co-authors of S Spinaci
This figure shows the co-authorship network connecting the top 25 collaborators of S Spinaci.
A scholar is included among the top collaborators of S Spinaci based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Spinaci. S Spinaci is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Blomberg, Bjørn, et al.. (2001). The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis.. PubMed. 79(1). 61–8.144 indexed citations
3.
Spinaci, S, et al.. (1999). Structures required, roles and responsibilities in maintaining laboratories for quality assurance of anti-tuberculosis fixed-dose combinations in accordance with the IUATLD/WHO statement.. PubMed. 3(11 Suppl 3). S368–70; discussion S381.2 indexed citations
4.
Blomberg, Bjørn, et al.. (1999). Estimate of the global market for rifampicin-containing fixed-dose combination tablets.. PubMed. 3(11 Suppl 3). S292–300; discussion S317.9 indexed citations
5.
Blomberg, Bjørn, Mary Ellen Kitler, Julie B. Milstien, et al.. (1999). Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?. PubMed. 3(11 Suppl 3). S371–80; discussion S381.3 indexed citations
6.
Maher, Dermot, P Chaulet, S Spinaci, & A D Harries. (1997). Treatment of tuberculosis: guidelines for national programmes. Second edition.. 1–77.30 indexed citations
7.
Pío, Antonio, et al.. (1997). National tuberculosis programme review: experience over the period 1990-95.. PubMed. 75(6). 569–81.32 indexed citations
8.
Raviǵlione, Mario, P Sudre, Hans L. Rieder, S Spinaci, & A. Kochi. (1993). Secular trends of tuberculosis in western Europe.. PubMed. 71(3-4). 297–306.214 indexed citations
9.
Raviǵlione, Mario, Philippe Sudre, Hans L. Rieder, S Spinaci, & Arata Kochi. (1992). Secular trends of tuberculosis in Western Europe: Epidemiological situation in 14 countries. 29–29.14 indexed citations
Arossa, W, et al.. (1982). A survey on spirometer calibration. Part one: Census and in field control of devices.. PubMed. 72(3). 177–82.1 indexed citations
18.
Sulotto, F, et al.. (1980). Radiographic and functional changes following exposure to different types of asbestos.. PubMed. 565–9.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.